Genetic engineering for medical purpose is considerably motr acceptable to the general public than GE of food crops (Small, Parminter, &Fisher,2005). Proponents hope that numerous medicines will be able to be grown in GE plants and/or GE animals and produced more cheapy than through current techniques. A biotech company, SemBiosys, has summitted an Investigational New Drug application for safflower-produced recominant human insulin to the U.S. FDA(SemBioSys, 2008).